Cargando…

New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement

Since the discovery of autoimmunity as the main pathophysiologic process involved in type 1 diabetes, many attempts have tried to delay or stop beta cell destruction. Most research protocols in humans have investigated the effects of therapeutic agents targeting specific steps of the autoimmune resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Couri, Carlos E. B., Malmegrim, Kelen C. R., Oliveira, Maria C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968392/ https://www.ncbi.nlm.nih.gov/pubmed/29868031 http://dx.doi.org/10.3389/fimmu.2018.01086

Ejemplares similares

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2020)

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: Malmegrim, Kelen C. R., et al.
Publicado: (2017)

Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis
por: Kawashima-Vasconcelos, Marianna Y., et al.
Publicado: (2022)

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)

Stem cell therapy for diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2011)

Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients
por: de Lima, Kalil A., et al.
Publicado: (2016)

The Effect of Immunosuppressive Adjuvant Kynurenine on Type 1 Diabetes Vaccine
por: Sun, Jing, et al.
Publicado: (2021)

Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2016)

AZDAST the new horizon in antimicrobial synergism detection
por: Ziaei-Darounkalaei, Navid, et al.
Publicado: (2016)

Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II
por: Malmegrim, K. C. R., et al.
Publicado: (2022)

Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon
por: Pali-Schöll, Isabella, et al.
Publicado: (2020)

Editorial: Oropharyngeal and nasopharyngeal microflora: new horizons in human immunity and clinical practice
por: Zhu, Chenyi, et al.
Publicado: (2023)

Macrophage Polarization in Leishmaniasis: Broadening Horizons
por: Tomiotto-Pellissier, Fernanda, et al.
Publicado: (2018)

Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy
por: Penaforte-Saboia, Jaquellyne G., et al.
Publicado: (2017)

Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes
por: Yang, Mei-Ling, et al.
Publicado: (2022)

Expanding Horizons in Complement Analysis and Quality Control
por: Frazer-Abel, Ashley, et al.
Publicado: (2021)

T Follicular Helper Cells As a New Target for Immunosuppressive Therapies
por: Yan, Lin, et al.
Publicado: (2017)

Stem cell transplantation for type 1 diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2009)

Molecular Pathways Mediating Immunosuppression in Response to Prolonged Intensive Physical Training, Low-Energy Availability, and Intensive Weight Loss
por: Sarin, Heikki V., et al.
Publicado: (2019)

Lower Insulin-Dose Adjusted A1c (IDAA1c) Is Associated With Less Complications in Individuals With Type 1 Diabetes Treated With Hematopoetic Stem-Cell Transplantation and Conventional Therapy
por: Penaforte-Saboia, Jaquellyne Gurgel, et al.
Publicado: (2019)

Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes
por: Vig, Saurabh, et al.
Publicado: (2021)

Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature
por: Habibi, Azam, et al.
Publicado: (2023)

Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
por: Wang, Man, et al.
Publicado: (2023)

The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
por: Bartell, Nicholas, et al.
Publicado: (2018)

New horizons in Biophysics
por: Moylan, Elizabeth C
Publicado: (2011)

Immunosuppressive Mechanisms of Regulatory B Cells
por: Catalán, Diego, et al.
Publicado: (2021)

Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis
por: Toren, Eliana, et al.
Publicado: (2021)

Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy
por: Bauzon, Maxine, et al.
Publicado: (2014)

Androgen-Induced Immunosuppression
por: Gubbels Bupp, Melanie R., et al.
Publicado: (2018)

Enhanced T Cell Glucose Uptake Is Associated With Progression of Beta-Cell Function in Type 1 Diabetes
por: Tang, Rong, et al.
Publicado: (2022)

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis
por: de Jong, Tamarah D., et al.
Publicado: (2019)

New Horizons.
Publicado: (1876)

New Horizons
por: Dogra, Vikram
Publicado: (2011)

Paravalvular Leak After Transcatheter Aortic Valve Replacement: Smoke on the Horizon?
por: Moreno-Samos, Jose Carlos, et al.
Publicado: (2019)

Enhancing Beta Cell Replacement Therapies: Exploring Calcineurin Inhibitor-Sparing Immunosuppressive Regimens
por: Caldara, Rossana, et al.
Publicado: (2023)

New Horizons for Modern Cosmology
por: Kamionkowski, Marc, et al.
Publicado: (2009)

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
por: Li, Yiliang, et al.
Publicado: (2018)

Case Report: Azathioprine: An Old and Wronged Immunosuppressant
por: Chocair, Pedro R., et al.
Publicado: (2022)

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?
por: Zhang, Yuzhuo, et al.
Publicado: (2022)

Editorial: Immunosuppressive disease in poultry
por: Li, Charles, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qh8msgdbgkll9fjtd543u082gg